Search Result "RBV dose adjustment"
Impact of Dose Reduction on the Efficacy of Triple Therapy for Patients Infected with Genotype 1b and High Viral Loads
Ebook: Advances in Modern Medicine
Volume: 1 Year: 2017
Author(s): Hiroshi Kohno,Hirotaka Kouno,Toshiki Yamaguchi,Atsushi Yamaguchi,Toshio Kuwai
Doi: 10.2174/9781681080239117010032
The Treatment of Chronic Hepatitis C not Responding to Interferon
Journal: Current Pharmaceutical Design
Volume: 8 Issue: 1 Year: 2002 Page: 967-975
Author(s): Raffaele Cozzolongo, Renato Cupone, Onofrio G. Manghisi
Predictability of Sustained Virological Response to Pegylated Interferon Alpha-2b Plus Ribavirin Therapy by Week-8 Viral Response in HIVPositive Patients with Chronic Hepatitis C Virus Infection
Journal: Current HIV Research
Volume: 7 Issue: 4 Year: 2009 Page: 447-455
Author(s): E. Angeli, A. Mainini, A. Cargnel, C. Uberti-Foppa, A. Orani, R. Carbone, M. Andreoni, M. Schiavini, R. Giorgi, G. Rizzardini, G. Gubertini
Consensus Treatment Guidelines and Recommendations to Treat Hepatitis-C Infected Populations
Ebook: Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815123432123010010
Treatment Recommendations for Harder-to-Cure and Vulnerable Populations
Ebook: Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815123432123010011
Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C
Journal: Current Pharmaceutical Design
Volume: 8 Issue: 1 Year: 2002 Page: 977-980
Author(s): Antonio Ascione, Massimo De Luca, Giovan Giuseppe Di Costanzo, Francesco aolo Picciotto, Alfonso Galeota Lanza, Carmine Canestrini, Filomena Morisco, Concetta Tuccillo, Nicola Caporaso
Obesity and its Relationship with Covid-19: A Review of the MainPharmaceutical Aspects
Journal: Current Pharmaceutical Biotechnology
Volume: 25 Issue: 13 Year: 2024 Page: 1651-1663
Author(s):
Direct-acting Antivirals for HIV/HCV Co-infected Individuals: As Good as it Gets?
Journal: Current HIV Research
Volume: 15 Issue: 6 Year: 2017 Page: 422-433
Author(s): Giuseppe Bruno,Annalisa Saracino
Chronic Hepatitis C in HIV-Infected Patients: Those Who More Need Therapy are Those Who Respond Less
Journal: Infectious Disorders - Drug Targets
Volume: 6 Issue: 1 Year: 2006 Page: 57-68
Author(s): Vincent Soriano, Marina Nunez, Javier Garcia-Samaniego, Pablo Labarga, Nuria Simarro, Luz Martin-Carbonero, Miriam Romero, Belen Ramos, Pablo Barreiro
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 12 Year: 2014 Page: 1391-1404
Author(s): I. Gentile,F. Borgia,N. Coppola,A.R. Buonomo,G. Castaldo,G. Borgia